Month: July 2024

Home 2024 July
New Hope in HIV Prevention: Biannual Injections Versus Daily Pill
Post

Revolutionizing HIV Prevention: The Promise of Lenacapavir Injections

The daily use of a pill such as Truvada has been a mainstay of the fight against HIV infections for over a decade. This kind of preventive medication, called pre-exposure prophylaxis, or PrEP, has demonstrated impressive efficacy in clinical trials, with up to 99% success rate in preventing new HIV infections that are contracted through...

Improving Prostate Cancer Outcomes with Advanced PET/CT Imaging Technology
Post

Major Breakthrough in Prostate Cancer Imaging: University of Alberta’s PET/CT Study

In comparison to the traditional MRI method, a new tracing agent for PET/CT imaging provides better accuracy in determining the extent of prostate cancer, as shown by a recent study by researchers at the University of Alberta. This is especially true for intermediate- and high-risk cases. This ground-breaking study, which highlights the important developments in...

osteoporosis
Post

Osteoporosis: The Silent Disease That Strikes Without Warning

Since osteoporosis usually goes undetected until a fracture happens, it is sometimes referred to as an unseen disease. Because there are no visible signs of the internal degradation occurring, the slow weakening of bones remains unnoticed. Nahid J. Rianon, MD, a geriatrician at UT Physicians Center for Healthy Aging – Bellaire Station, explained that although...

From Party Drug to Antidepressant: The Evolution of Slow-Release Ketamine
Post

Ketamine’s New Role: A Slow-Release Pill for Severe Depression

Introduction: Ketamine has shown promise as a treatment for severe depression, despite its initial reputation as a party drug and horse tranquilizer. Although ketamine is often given intravenously in a clinical environment, new developments indicate that a slow-release pill may increase accessibility to this medication and lessen unpleasant side effects. This discovery may be revolutionary...